| Pharmaceuticals - Anti-infectives, Oncology, Neurology, Pain Management | Specialized injectable drugs, IV fluids, oncology and pain management formulations, and consumer healthcare products. | Strong R&D capabilities, WHO and German GMP certifications, exclusive patented products, and international manufacturing footprint providing high entry barriers. | Pharmaceutical distributors, hospitals, clinics, and pharmacies worldwide focusing on B2B market with growing consumer healthcare reach. | Patented antibiotics and oncology drugs command higher margins due to clinical significance and limited competition. | 639 | 100 | Revenue from drug sales through B2B pharmaceutical channels and hospitals, supplemented by emerging OTC product sales. | Direct sales with negotiated contracts and standard pharmaceutical pricing; limited recurring contracts for select products. | Product innovation, expanded therapeutic areas, digital transformation, global regulatory approvals, and addressing antimicrobial resistance. | ELORES, Meropenem, Taxedol, Cytomib, R3SET |
